Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Oligonucleotide Therapeutics. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel patent CN115181147B enables high-purity nucleoside intermediates with streamlined synthesis for cost-effective pharmaceutical manufacturing supply chains.
Patent CN104211741B reveals a scalable synthesis method for deuterated thymidine phosphoramidites, offering high purity and cost-effective manufacturing solutions for global research.
Novel enzymatic route for 2'-O-propynyl-guanosine. Higher yield, simplified process for oligonucleotide manufacturing supply chain.
Patent CN118852303A details a novel aminolysis method for cytidine vinyl phosphate, offering high purity and cost reduction in nucleoside manufacturing for global supply chains.
Patent CN113461743A reveals a cost-effective 4-step route for crosslinkable nucleosides, eliminating chromatography and enabling high-purity oligonucleotide manufacturing.
Novel one-pot synthesis method for high-purity nucleoside dimer phosphoramidites. Reduces steps and reagent costs for oligonucleotide manufacturing.